Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/32295
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 17778/20119 (88%)
造访人次 : 12256326      在线人数 : 338
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.cnu.edu.tw/handle/310902800/32295


    標題: GW0742 activates peroxisome proliferator-activated receptor delta to reduce free radicals and alleviate cardiac hypertrophy induced by hyperglycemia in cultured H9c2 cells
    作者: Cheng, Kai-Chun
    Chang, Wei-Ting
    Li, Yingxiao
    Cheng, Yung-Ze
    Cheng, Juei-Tang
    Chen, Zhih-Cherng
    貢獻者: Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med
    Chi Mei Med Ctr, Dept Cardiol
    Chi Mei Med Ctr, Dept Med Res
    Chi Mei Med Ctr, Dept Emergency Med
    Chang Jung Christian Univ, Grad Inst Med Sci
    Chia Nan Univ Pharm & Sci, Dept Pharm
    關鍵字: cardiac hypertrophy
    GSK0660
    GW0742
    H9c2 cells
    peroxisome proliferator-activated receptor (PPAR)
    日期: 2018-11
    上傳時間: 2019-11-15 15:48:31 (UTC+8)
    出版者: WILEY
    摘要: Peroxisome proliferator-activated receptor (PPAR), the predominant PPAR subtype in the heart, is known to regulate cardiac function. PPAR activation may inhibit cardiac hypertrophy in H9c2 cells while the potential mechanism has not been elucidated. Then, H9c2 cells incubated with high glucose to induce hypertrophy were used to investigate using GW0742 to activate PPAR. The fluorescence assays were applied to determine the changes in cell size, cellular calcium levels, and free radicals. Western blot analyses for hypertrophic signals and assays of messenger RNA (mRNA) levels for hypertrophic biomarkers were performed. In H9c2 cells, GW0742 inhibited cardiac hypertrophy. In addition, increases in cellular calcium and hypertrophic signals, including calcineurin and nuclear factor of activated T-cells, were reduced by GW0742. This reduction was parallel to the decrease in the mRNA levels of biomarkers, such as brain/B-type natriuretic peptides and -myosin heavy chain. These effects of GW0742 were dose-dependently inhibited by GSK0660 indicating an activation of PPAR by GW0742 to alleviate cardiac hypertrophy. Moreover, free radicals produced by hyperglycemia were also markedly inhibited by GW0742 and were later reversed by GSK0660. GW0742 promoted the expression of thioredoxin, an antioxidant enzyme. Direct inhibition of reactive oxygen species by GW0742 was also identified in the oxidant potassium bromate stimulated H9c2 cells. Taken together, these findings suggest that PPAR agonists can inhibit free radicals, resulting in lower cellular calcium for reduction of hypertrophic signaling to alleviate cardiac hypertrophy in H9c2 cells. Therefore, PPAR activation can be used to develop agent(s) for treating cardiac hypertrophy.
    link: http://dx.doi.org/10.1002/jcb.27270
    關聯: Journal of Applied Polymer Science, v.119, n.11, pp.9532-9542
    显示于类别:[藥學系(所)] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    10.1002-jcb.27270.pdf753KbAdobe PDF161检视/开启
    index.html0KbHTML295检视/开启


    在CNU IR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈